Botanix Pharmaceuticals Limited
BXPHF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $825,318 | $939,226 | $469,691 | $253,377 |
| - Cash | $64,967 | $48,437 | $79,308 | $18,313 |
| + Debt | $32,106 | $866 | $0 | $0 |
| Enterprise Value | $792,458 | $891,655 | $390,383 | $235,064 |
| Revenue | $5,412 | $378 | $1,692 | $378 |
| % Growth | 1,333.2% | -77.7% | 347.6% | – |
| Gross Profit | $2,849 | -$831 | -$982 | -$3,025 |
| % Margin | 52.6% | -220.1% | -58.1% | -800.4% |
| EBITDA | -$49,798 | -$30,853 | -$8,401 | -$2,759 |
| % Margin | -920.2% | -8,171% | -496.7% | -730% |
| Net Income | -$55,508 | -$30,888 | -$8,403 | -$5,467 |
| % Margin | -1,025.7% | -8,180.2% | -496.7% | -1,446.6% |
| EPS Diluted | -0.03 | -0.017 | -0.005 | -0.004 |
| % Growth | -74.1% | -214.8% | -42.1% | – |
| Operating Cash Flow | -$48,023 | -$30,562 | -$4,367 | -$3,760 |
| Capital Expenditures | -$196 | -$91 | -$77 | -$14,776 |
| Free Cash Flow | -$48,219 | -$30,652 | -$4,444 | -$18,536 |